<?xml version="1.0" encoding="UTF-8" standalone="no"?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0"><channel><title>Pharmaguideline</title><description>Pharmaguideline provides all pharmaceutical regulatory guidelines including quality control, quality assurance, microbiology, and production departments. Get all SOPs of these all departments. Calibration and operating procedures of all quality control instruments and operating procedures of all production equipment are also provided on the website. All GMP topics are also covered for quality assurance.</description><managingEditor>noreply@blogger.com (Dr. Ankur Choudhary)</managingEditor><pubDate>Sun, 6 Sep 2026 18:45:50 +0530</pubDate><generator>Blogger http://www.blogger.com</generator><openSearch:totalResults xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/">2353</openSearch:totalResults><openSearch:startIndex xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/">1</openSearch:startIndex><openSearch:itemsPerPage xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/">30</openSearch:itemsPerPage><link>https://www.pharmaguideline.com/</link><language>en-us</language><itunes:explicit>no</itunes:explicit><itunes:subtitle>Pharmaguideline provides all pharmaceutical regulatory guidelines including quality control, quality assurance, microbiology, and production departments. Get all SOPs of these all departments. Calibration and operating procedures of all quality control in</itunes:subtitle><itunes:owner><itunes:email>noreply@blogger.com</itunes:email></itunes:owner><xhtml:meta content="noindex" name="robots" xmlns:xhtml="http://www.w3.org/1999/xhtml"/><item><title>Regulatory Observations in Pharmaceutical Manufacturing</title><link>https://www.pharmaguideline.com/2026/09/regulatory-observations-in-pharmaceuticals.html</link><category>GDP</category><category>GMP</category><category>Regulatory</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sat, 5 Sep 2026 13:13:38 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-6142211173095177182</guid><description>When regulatory authorities make observations, it signals an indication that the company's systems, processes and controls may not comply with regulatory standards. Observations do not imply necessarily that the company's products are flawed or that quality systems have failed in their entirety. Nonetheless, observations reflect concerns raised by the regulatory authorities that necessitate </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgGJ14atVuG4jyDe1DCeXdf3B0WJWALyLvtBb2Z_xUSd6oQlVUqS11QC1A6RcbbZpe4nH-UcJhQLM4rS_RTkYV1K36XFFCRcREn8NlefveLZmPFiwIaJ861vEv0MCidwXE6Dbr765KWcAOs6imhy9y3_dmQW2P5xdGLrbCFhGvjDYOHjCysqpovztr13JGb/s72-c/regulatory-observation.png" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Periodic Review in Pharmaceutical GMP Systems</title><link>https://www.pharmaguideline.com/2026/09/periodic-review-in-pharmaceutical-gmp.html</link><category>GDP</category><category>GMP</category><category>Quality Assurance</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Wed, 2 Sep 2026 20:35:31 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-2710809426025582140</guid><description>The periodic review is an essential part of a suitable Pharmaceutical Quality System. It allows examining the ongoing processes and understanding if a process, equipment, system, document or validated system still performs according to the requirements. In pharmaceutical production, problems arise not as a result of one major malfunction but are developed over time through continuous failures, </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgevPFzv3w7RU6N7KqgMJ53wYo3pJ4Twahb9AHaYJ7UQ8Y761H8sHwWLIDf6GsgsMReuduErNBWyygrp5jFtfSOwsZKkiWAcrK9eBaKce7RSGb7qnligxEeyKICX-IhMltxDnCn2oUEim8CUvwP6p1f1KPZtsp5XVYGuRzvWAjGl5_lXRQErYUcI_qp4q8n/s72-c/periodic-review.png" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Calibration Records in Pharmaceutical Manufacturing</title><link>https://www.pharmaguideline.com/2026/08/calibration-records-in-pharmaceuticals.html</link><category>Calibration</category><category>GDP</category><category>GLP</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Mon, 31 Aug 2026 22:03:45 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-915250011119167940</guid><description>Calibration records are critical quality records kept by pharmaceutical manufacturers. A long list of measuring instruments is frequently used in making decisions which can impact product quality.A calibration certificate will not necessarily ensure that the entire calibration system works as intended. The company needs to know what equipment was calibrated, with what standard, when it was done, </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjMsyn2ZS1TkV6oZ1_haEvuKumrPEWNrQe1LtOArBx_rbgW7M1b2nzdlMouAmj4eJ2uw776vs5cMLPsoQenQEYvJP_41GcibCbXmMdKvSQ8eLcEjL7U6mR-9efjC7bdwcGRso3Kqo4SBM2HZzlRMFpliJgc2Cl4RnJMqP-nXDhRG8-3E0IgDr7_7GF9HSFx/s72-c/calibration-records.png" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Pharmaceutical Document Management System Guide</title><link>https://www.pharmaguideline.com/2026/08/pharmaceutical-document-management-system.html</link><category>GDP</category><category>GMP</category><category>Quality Assurance</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sat, 29 Aug 2026 22:01:40 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-6062523081721063891</guid><description>A vast volume of highly regulated data is produced by a drug-producing company on a daily basis. Various documents, such as Standard Operating Procedures (SOPs), specifications, protocols, documents, forms, policies and log books must be maintained in a precise and timely manner ensuring their availability at all times.Managing all of those documents using folders, spreadsheets and paper files </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh2KiyaEY-4_mPNqmUwvZovjyk4xhMtJcXmlEu1azsEYpNQo3b8_gtCCs31c0G_m-4ZIASaNetEoDPw4eZ22zYwiZ_Um9S95KMpHVL9FEpNb3vE4TKyjDBjdj8wlAK8UZ86OnfGFPhqbnKWCgZEWUWPkjd7Ce1lvfcAGHYo6z8rF7dxbs0WL0SXcKxHVhhk/s72-c/dms.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Documentation Gaps in Pharmaceutical GMP Systems</title><link>https://www.pharmaguideline.com/2026/08/documentation-gaps-in-pharmaceuticals.html</link><category>GDP</category><category>GLP</category><category>Quality Assurance</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Wed, 26 Aug 2026 22:57:02 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-238146255327029755</guid><description>Documentation refers to the records of various events throughout the process of pharmaceutical manufacturing. In reality, however, this term is much broader. Properly organized documentation system enables a company to recreate any operations, monitor who performed a specific operation, trace ways of how this operation had been accomplished and assess if and how this operation was done in a </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjzUf-1cCqetQlxFBvs4L26g6Vpjcan7Bw_67eXcEIRqnKnaPkFbaZEPeEh8CZKX_559NFYFgoceOOCmpbf2kkqLYNxzCi5AUG51LS8jEF-jQGMOnM4Kh8LtDL8I0aCDiAQGv6jTcGiVZi1n8zIxTckNYlVFWFJRzIVxp2sgYViV_ZxYUjp6l3wllueqz1u/s72-c/doc-gap.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Effective Validation in Pharmaceutical Manufacturing</title><link>https://www.pharmaguideline.com/2026/08/effective-validation-in-pharmaceutical.html</link><category>GMP</category><category>Quality Assurance</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Mon, 24 Aug 2026 22:25:34 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-3945660869637362641</guid><description>Validation can be defined as written proof showing that a process system or equipment is working as it was meant to be. In reality, however, successful validation is much more complicated than simply going through the protocol steps and obtaining signatures.An important question that has to be answered during validation is whether or not the process is really running as planned and how this can </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgIHIWHtgAyVz-KhRjdXuHrucFS9qWjIrkJ2-Rcw8ojQTOg15Le8I33uuTzynZrsKwsUPkQ5fGfi1sNUiZUbedLqVw9pskr4ar03jm5toqQgtxnZoMnbK38GUOzzEDyCAmXLcu6MLfxBaU6l_P3_xtSDltoeCz7soJ1jrt3g7xQBoxoSP2tpqK5dwrVyTwc/s72-c/effective-validation.jpg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Training Records Management in Pharmaceuticals</title><link>https://www.pharmaguideline.com/2026/08/training-records-management.html</link><category>GDP</category><category>GMP</category><category>Quality Assurance</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sat, 22 Aug 2026 20:50:39 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-2647807498078436000</guid><description>At any pharmaceutical production facility, training records serve as proof that an employee has attended a training program. It supports the quality system by showing that the workforce is properly qualified to perform their responsibilities.When an audit or a regulatory inspection happens, training records are examined together with SOPs, deviations, CAPA, batch records and qualification papers.</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjzoXsoI4MxDKHGAPqEiblPZkZWgF-0ExSxMJnAjWD9ZZkL4ivBoN4bw5Q1GpOsKP1dIQIs21k8WeYpZ-1Ttv-x6a_GVR6jKtuLJEBNVE6QEJHOduGztU9Q7OljlKGDNhjdsJGFb6HtBMFysxaPFf_pbWbwP_CM5wl1p5SbeeLZ4tOoepKjNgtQiRjMJ2Sn/s72-c/training-management.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Aseptic Manufacturing Process in Pharmaceuticals</title><link>https://www.pharmaguideline.com/2026/08/aseptic-manufacturing-process.html</link><category>HVAC</category><category>Production</category><category>Sterile</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Thu, 20 Aug 2026 21:14:11 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-1012976278589742538</guid><description>Pharmaceutical manufacturing has aseptic production as one of its toughest processes because the end product has to stay sterile without the need of terminal sterilization after filling. This implies that the process must include control of microorganisms and the contamination due to particles at every manufacturing step, starting with the preparation of the components, through the actual filling</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjEljm_qG7Q7giZKvU59RN7vu329vicjvyMBczFcLOqGjjbK_c-RD-wlhI41IH5fUufU7GZycbYW1KHleqZjZgz23wQ8uuPm7CSg-3_vGtf_guJ3wKMc7r4jQml5b6RjIqo13JeZMRadUku0MlzjbqTy6KMVuxAFDLSUz268O6ialjQZ-ylOCGdXyEpARHI/s72-c/sterile-manufacturing-process.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Gowning Procedure in Sterile Manufacturing</title><link>https://www.pharmaguideline.com/2026/08/gowning-procedure-in-sterile-manufacturing.html</link><category>GMP</category><category>Sterile</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Tue, 18 Aug 2026 22:07:50 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-5155560409673391712</guid><description>In a sterile manufacturing environment, personnel represent one of the greatest possible causes of contamination. A cleanroom can have a suitable HVAC system in place, good equipment, validated cleaning practices and effective environmental monitoring systems; nevertheless bad working practices can lead to issues with contamination control.It is obvious, therefore, that gowning is not merely the </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiXF-8pALcdxAWt7va9zN0-PQvvfGWNkOJcz3Y5FKF5uHhZj04oYl5MFV5F5f9c0ZgCq5Ew0-vRpRdKn4INNosAIdXx3GwCm_8-KYHkE49Q7GMPHCyoLGaaUxH3-ClVURX6X_InASX8FrXrvdzg4f4cRfBVl0J-okTvuRF_X0Rmc4VJ9nZUTjkE4QpNTXmS/s72-c/sterile-manufacturing.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Validation of Continuous Manufacturing Processes</title><link>https://www.pharmaguideline.com/2026/08/validation-of-continuous-manufacturing-processes.html</link><category>GMP</category><category>Quality Assurance</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sun, 16 Aug 2026 23:17:14 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-3598332880847704231</guid><description>Continuous manufacturing affects the way processes are developed, certified and validated in the pharmaceutical industry. Instead of manufacturing pharmaceutical products in batches, which means a fixed amount of material produced until it is stopped, continuous manufacturing refers to uninterrupted or semi-constant processing of materials through the interconnected processes involved in the </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhdtzVbkSQ65-8HUkFVo90bA6V-u_7qc3ESYyDU6tITJxUxloS9PdbV9MvkZ4JqRb07nG0jDqbOmgX8Vk0omOGyyMxt4_o0kl6ldzSmAcKsMNYceHdb3BlC-xDYFcHSwoSMaKaUcLt699pbwafukcrPEHUFfmi5nPw3pT4_hGSeW36roZvQe5CtSkZhpea0/s72-c/continuous-manufacturing-validation.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Validation Strategy for Contract Manufactured Products</title><link>https://www.pharmaguideline.com/2026/08/validation-strategy-for-contract-manufacturing.html</link><category>GDP</category><category>GMP</category><category>Regulatory</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Fri, 14 Aug 2026 22:00:27 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-4178657325717600901</guid><description>The decision to outsource pharmaceutical manufacturing is an important aspect in the operations of many businesses. Contract Manufacturing Organizations (CMOs) offer extra advantages, such as manufacturing capacity and technological capabilities and allow Marketing Authorization Holders (MAHs) to concentrate on development and commercialization. Nevertheless, it is crucial to keep in mind that </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjOIoJmyGPEo9ssT7BXy_lXLeG-AODPqdoAFFSna4DASxsRJ-0R4aCGP2R7CT43Dk7eI1WakpfKitrOO0uLhGmqCi3J22uc3fxuArydwEUDOwTrwcW_9q8RBRSxRpXoAlgq6MMjGvQLgGtOcR07GpUbu30XWtgiXMBUbowBxII_1mqhBez2AUOIQNOYo72H/s72-c/contract-manufacturing.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Critical Process Parameters (CPP) in Pharmaceuticals</title><link>https://www.pharmaguideline.com/2026/08/critical-process-parameters-cpp.html</link><category>GDP</category><category>GMP</category><category>Production</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Wed, 12 Aug 2026 22:27:15 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-2210415786446540395</guid><description>Imagine that a tablet compression machine is correctly functioning as highlighted in the process instruction document. The speed of compression is optimal, the machine is validated and the people running the process are competent. Still, the finished tablets fail the dissolution test. An inquiry reveals that the cause of the issue lay with unnoticed increase in the moisture of granules prior to </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjKA_HcbWi_9Fnyn_HyfQr21NS4tX-HGgpRoq-6J-xKjcKKhWAxEYb3Br7RZSV2OtmZSlxj5Jw_XQKcsy-Fv5mdTOjgV3025UzSoZ_IHv3yREWjnQE3C7dXuM8Xngel5r4pwaWaFAWL09MFBmD8eUk41TO6NNfR2N9o5n0-thaZqn9cQKReTB1O88hEG6d4/s72-c/cpp.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Failure Mode and Effects Analysis (FMEA) in Pharmaceuticals</title><link>https://www.pharmaguideline.com/2026/08/failure-mode-and-effects-analysis-fmea.html</link><category>GDP</category><category>GMP</category><category>Quality Assurance</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Mon, 10 Aug 2026 23:17:19 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-3488888309128980683</guid><description>The pharmaceutical industry operates on the preventative principle of failures, which means production failures are avoided before they occur and have an impact on product quality or patient safety. While analyzing deviations, complaints and investigations can provide much needed lessons once the event has already taken place, the best quality systems work on the principle of predicting risks and</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiFAlsd0rN2csfy1BD_3A7M7mvY8w-tOCAehISmRgwB0mp-ZAqwRFK_3dc1MLiQcYPdE0EoL8Y2Ktxvzl3YF0VqD8b8DGBGLyxQaqzqZXv3unI-4tzo0hD33Imfr0UYlSsXWOZYjY4_3PHWCE1jch0pkV5x3erGebo7KhCsvf-Y0Dm__gq5cYY1Te0XGif1/s72-c/fmea.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Handling Out of Expectation (OOE) Results in Pharmaceuticals</title><link>https://www.pharmaguideline.com/2026/08/handling-out-of-expectation-ooe-results.html</link><category>GDP</category><category>OOS</category><category>Quality Control</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sat, 8 Aug 2026 14:59:43 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-3746755357589004450</guid><description>Not every problem with quality in pharmaceutical production is an OOS situation. There are plenty of cases when testing gives results in compliance with specifications but at the same time differing significantly from the past records of results or from expected performance. Such contradictions are known as OOE results.Even though OOE results may not impact batch release in any way, investigating</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh53HOYkjS-yV-1fwbm6FoWe58W8OQNebj5nprTOdVLe_Gyp-y6UDBGIWurARNEjv8kF2vdC3eRRrt3RXsjHQmgo7p3WqNyRoPXinuSpH2sEfgoVe5WVBj7njtqQ6y6ov98TgPBV1_RnSj-jdJT3AlULkdGCRn3wkphVsARYcucfZoQmFnBNf3ggRK50XYT/s72-c/ooe.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Validation Failure Due to Poor Risk Assessment: Case Study</title><link>https://www.pharmaguideline.com/2026/08/validation-failure-due-to-poor-risk-assessment.html</link><category>GMP</category><category>Regulatory</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Thu, 6 Aug 2026 22:19:43 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-3438473789238761429</guid><description>Validation failures are usually due to improper testing, equipment failure, or mistakes made by the operator. One of the most common causes of validation failures is not mentioned often enough, which is the poor risk assessment done in the planning phase. Inadequate identification and assessment of potential risks can lead to improper validation protocols, which could mean that critical </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh9itNcKe2rkF6YLU_9unVHsZo9iuXTr8avoHugD7Vhu4Njc_YNy9b3oZYl9PKUTUtLDPoT2vBbbTD0I27T2lUOlope0RE2usBP5Zy2gfHMljoedHtezVn-DDewit-u5nxhoK72b5TwvHD0hOSNQ9ciyY8d1ZvPdBwCqpRirh-EBt3E0KJk5pVsikVw42ZF/s72-c/validation-failure.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Validation Report in Pharmaceuticals: A Practical Guide</title><link>https://www.pharmaguideline.com/2026/08/validation-report-in-pharmaceuticals.html</link><category>GDP</category><category>Quality Assurance</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Tue, 4 Aug 2026 22:02:42 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-1675150069356924132</guid><description>Validation tests do not finish once the testing phase has been accomplished. A good validation report proves the outcome of the validation process and contains information about what was tested, the method applied for conducting tests, the results obtained and difficulties faced during the tests. The validation report provides written evidence that a facility, a system, equipment, utility, </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhw8_m6fy5K1vuHRBhWXzi2gMjfBIplhxEfrOsl5Z-GrI-NFb5KuaKKftUqPHkEa-PMnYVVnkjDRV4GGRhjWm_BKI8Syd6K-rC6103czAvNmxts-29YoiD1r5KGjz8BFYpNu8qohjksXndLSReRcBvaZU9KMPRN889p7wdMZPGMVInuDOJvP268xSociq5D/s72-c/validation-report.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Best Practices for Reviewing Validation Documents</title><link>https://www.pharmaguideline.com/2026/08/best-practices-for-reviewing-validation-documents.html</link><category>GDP</category><category>Quality Assurance</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sun, 2 Aug 2026 22:25:35 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-1065070328918199917</guid><description>Validation documents go beyond regulatory documentation; they are written proof that the pharmaceutical premises, equipment, utilities, computerized systems, analytical methods, and manufacturing methods work properly on a permanent basis. Validation document quality establishes, among other things, the trust level of regulatory authorities in the company’s performance and products. However, many</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiBj39ncAEQdWRCRsMnzAWwsavLibLPFC9cwJ-30MW2-wlvr-zBGQW8SJufbh-gEt7GC2h2RkXHdp6Vh8xbz6lbmRXRM4ilW0wWheo5iRDiyQ0JqDu01has0q8qcZQeieqExxeLFf0eQCUFEKIIXzmIublRhpECnMxgIL6IDdDYMEEv0YTlaSoYdlVhs_fl/s72-c/document-review.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Documentation Practices That Impress Inspectors</title><link>https://www.pharmaguideline.com/2026/07/documentation-practices-that-impress-inspectors.html</link><category>Audit</category><category>GLP</category><category>Regulatory</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Fri, 31 Jul 2026 18:49:17 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-3114223473489893249</guid><description>During an inspection by regulatory authorities, various documentation reveal the working of a pharmaceutical facility. Although inspectors spend only few hours on the production site, they spend days scrutinizing batch reports, logbooks, evaluation documents and quality assurance documents. This documentation indicate whether processes have been implemented correctly and scientific rationale of </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh1IsvEGsCQGCTMlQQNnMHlXpDuwh-2emLFq-eAMefiQRiYkWdkAmquCH1hxWuOogJ3P-Ebho6vohsfw8-NipIP4Xx5SyL4b0hL1vExEXdbkXbAnMvsmFwM6v9m26-D9gFPEZN5tjEVk-_f0uvPNALcZK23-VI9BWn5mmKfmWT1UdzJ0AMhkTcPVdbDCxv8/s72-c/proper-documentation.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Troubleshooting Inconsistent Batch Performance in Pharmaceuticals</title><link>https://www.pharmaguideline.com/2026/07/troubleshooting-inconsistent-batch-performance.html</link><category>GDP</category><category>GMP</category><category>Quality Assurance</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Wed, 29 Jul 2026 22:56:38 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-1807561669757403959</guid><description>The core of pharmaceutical production is the concept of batch consistency. Every batch must conform with all predetermined specifications regarding quality, purity, potency, dissolution, uniformity, and stability of the product. Noncompliance of batches, even if they were produced in the same manner, raises questions regarding the reliability of the manufacturing process and its control over the </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiWjuN2GDrfDWr9lomw1Eu0lNzOq0iD8ArxAUJXf5zQzFfKPIlZv5k3Q-wH_IGz4RAXsJ-F9Yc4Hnpcllqt04i_YEJIovp9pnXUaHhiDLNfWpsFtZof1nRcr1Es8KXvpgYrjrhhVCNG9MEp-g7dNZK_ANBBXW1YZJP97kK0NRfEXw1Fj8CXhbIOt57pkMs2/s72-c/batch-processing.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Inspection Readiness Timeline for GMP Inspections</title><link>https://www.pharmaguideline.com/2026/07/inspection-readiness-timeline-for-gmp.html</link><category>Audit</category><category>GMP</category><category>Regulatory</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Tue, 28 Jul 2026 19:48:21 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-8370762097040982361</guid><description>An inspection carried out according to regulations is one of the major moments in the life of a pharmaceutical production plant. Regardless of whether the inspection is done by FDA, EMA, WHO, MHRA or any other agency, the inspectors will demand a proof that the factory has been working in the compliance mode. They will not be impressed with an industrial facility that has been tidied up and </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhQhXtbwQIRrHspGUmhNlSo6FexoNua18zhaLkDOlYklYtibl0_2KqXnB11GlsKx7LGRhyCJs2BXYSZErqNkq2fxtlT1GfUOB0aw-ZooE58Sg1ZmNTTq1ZwAftVbium2BVRjcN2zuCeEEs4R2iIjuqgWh2jFTD7f7C9KaAtrSTUdjN1rJMY6lhHu157oj5s/s72-c/inspection-rediness-timeline.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Root Cause Analysis of Failed Cleaning Validation: A Practical Guide</title><link>https://www.pharmaguideline.com/2026/07/root-cause-analysis-of-failed-cleaning-validation.html</link><category>Cleaning</category><category>Cleaning Validation</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sun, 26 Jul 2026 20:08:34 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-8653425767162694102</guid><description>One of the hardest experiences that any pharmaceutical company could encounter is the failure of the cleaning validation process. There are negative implications from such a failure relating to product launch, as the failure leads to considerable concerns about the reliability of the cleaning process in terms of the prevention of cross-contamination.The answer to the question of whether the </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgACZM1_DYx1RyXaUH-KX8kYR8rwER4OKViL9NWwna0hmD5U8kMipVotyhKFoKkXusjGAnuPZi94aEnve7zlSC_OuQtbOuf_i4G8-WEUA2xyjXPdkvxcMX0NmteSiE4L-CcGTz6nkbh1G6lPNE1frgdbTAPIX-UVvxJ9TqRxWRiTPlANnLj1z9X21DyxCxT/s72-c/failed-batch-rca.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Utility Design Considerations for Efficient Pharmaceutical Manufacturing</title><link>https://www.pharmaguideline.com/2026/07/utility-design-considerations.html</link><category>Engineering</category><category>Equipment</category><category>GDP</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sat, 25 Jul 2026 18:14:51 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-1694448373200125085</guid><description>When pharmaceutical specialists speak about way of manufacturing effectiveness, they usually emphasize machinery, machinery automation or improvement of production methods. But in practice, many reasons of delays in production, quality non-compliance and sudden stoppage are connected with utility systems&amp;nbsp;that is not taken seriously enough.Utility systems, including water, steam, compressed </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjiFBZxoSWg-_l0Uqy7zlToOjTkjD21afku5-1vfL1-2vZdefrCCnglLVU4xxQGm9G-OfuUBq-GtfBx-kLcylB_y81dyglDClmmOt4M7Shsk1uxwlPKUqrzc0zQkW2jzeu3qfYSIG_2vS0kRCQV_zIIcX8NB7WhnCSkJE4tnl5Xt8Os1HAXAB3Hj1vpn5K5/s72-c/utility-area.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Steps to Calculate MACO for Cleaning Validation in Pharmaceuticals</title><link>https://www.pharmaguideline.com/2026/07/steps-to-calculate-maco-for-cleaning-validation.html</link><category>Cleaning Validation</category><category>Quality Control</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Thu, 23 Jul 2026 21:48:53 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-225351406926619773</guid><description>Cleaning validation is one of the most studied and analyzed processes during the pharmaceutical inspections since it demonstrates that the cleaning of production equipment can be performed with high quality and with full assurance that there would be no cross-contamination. While visual inspection of surface cleanliness is crucial, authorities also require companies to define the maximum </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgKWgIVHaft5-BIVLOZmaRXd8yhvUoI-pH5C79WKHsIJpbUrehcE-7xNv7Vdzy7R-GgmOwKdi2y6MzEtS47_9UoEf7WKuTfLOOon2nkSCPhtINVUe-Z7qbfFTSmt66iUzCshuzWEQBSAuWRV7DkwGGBtMOLjg2ZvXWI6g5BVndO-Pbe31B5ehV1R43cD2Fa/s72-c/maco-calculation.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Worst-Case Product Selection Using Risk Assessment in Validation</title><link>https://www.pharmaguideline.com/2026/07/worst-case-product-selection-using-risk-assessment-in-validation.html</link><category>Cleaning Validation</category><category>GMP</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Mon, 20 Jul 2026 17:36:39 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-2792699715458630166</guid><description>Verification tools are always limited although many pharmaceutical manufacturing sites manufacture various products utilizing the same machines. It is neither sensible nor scientifically acceptable to validate each product separately. In its place, authorities want manufacturers to select typical worst-case products through a documented risk analysis process. If the validation proves that </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgKzLP6SMOAxxcmNvVmCsmq4EdBHPjUGoHyZJrXE9HbTQD5mYQfn5BG-yF61DdjbXYUu38d7sRu7pwT6jftukKYkvqoyn50a_qqCZ9MBezMRhqcm_Mj56S0IS1oMs4gDIJPfdSFwI2rIT4soa1jkzLjW3voI6_j7vP2EIsPQeIMtgg5VEHpihT9_UpvP9wW/s72-c/worst-case-detection-1.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>How to Perform a Mock Audit to Simulate a Regulatory Inspection</title><link>https://www.pharmaguideline.com/2026/07/how-to-perform-mock-audit-to-simulate-audit.html</link><category>Audit</category><category>Quality Assurance</category><category>Regulatory</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Fri, 17 Jul 2026 22:25:44 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-7330580546018396314</guid><description>Each pharmaceutical producer hopes to successfully emerge from a regulatory inspection, which is not possible just because it wishes to do so. Food and Drug Administration (FDA) inspections, as well as other regulators like MHRA, EMA, WHO are scheduled as surprise or unnotified inspections, which quickly spot shortcomings missed by normal internal audits. The difference between a successful </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiOkHuDUhatBWhx-cvkjjYw3m0iU6St4P6KaLLhm3_wUobD1NxKZrmk47OnWC5T3qU3wIqfYIeWH7Ew8bKUE__-2AK7m5DKVAggmwmHOngLbXCwaydsVYQa-AKuIwPyOiu5MkEMrLrQYRSHz026_ygX-Lpez-DNPxKISh1YYos-XeajcYzfW5GUXnRiYwMF/s72-c/mock-audit.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>How to Calculate Sampling Size of Raw Materials | n, p and r Plans</title><link>https://www.pharmaguideline.com/2026/07/how-to-calculate-sampling-size-of-raw-materials.html</link><category>GMP</category><category>Quality Assurance</category><category>Stores</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Wed, 15 Jul 2026 20:27:38 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-6999076738787957944</guid><description>When raw materials are delivered to a manufacturing plant, they pose a threat to the quality of finished goods. The quality department cannot presume that every box, even though it comes from a certified supplier, is uniform and pure. This is why sampling plays such a crucial part in GMP compliance. One of the most common questions I get asked in my internal GMP training is how many containers </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgPSPWhlhN4vI8WQXihhRGbprqAPwhkdqKdsMpKUiIIYAvP8BFFEpn4K117VyHgdToTIQQP0Fe-VkCm8GEzxrmuyHVWghchR2N_VdlSsGggxz66NTn80-jrRraKeJhxEnfbE8H41SDTZK95JenGkCN5ttq0tYEZQ2AGDgt64cmg49W8YPE_oMdFjluz5WcN/s72-c/raw-material-sampling.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Eliminating Dead Legs in Pharmaceutical Piping Systems</title><link>https://www.pharmaguideline.com/2026/07/eliminating-dead-legs-in-piping-systems.html</link><category>Engineering</category><category>GMP</category><category>Water</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Mon, 13 Jul 2026 20:20:18 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-8984492405570895266</guid><description>The piping systems and water systems are made to carry vital services like PW, WFI, pure steam, process gases and CIP solutions without compromising product quality or microbial safety. However, even the most efficient water systems can present a risk of contamination when stagnant regions inside the piping system appear. The presence of dead legs is one of the main culprits responsible for </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhVPwoELBZYPYKk6wolExLPWxbc4qFCmeW0WS4K-LEcaBOMhzRROyvFwKdjV5hajsMDW29V_IwH3iKkmu3nl_IsJlx7ljVN5cT8NgEyIAsQAfeQvSinW6GNAH1DXz1Xr2towNPBaJPlyMKizBU23kgmNkhl_BUV9w8ng3V9sLZIQMcMjnQFWGiywAabtrPG/s72-c/dead-leg.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Validation of Dissolution Methods in Pharmaceutical Analysis</title><link>https://www.pharmaguideline.com/2026/07/validation-of-dissolution-methods.html</link><category>Quality Control</category><category>Test</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Sun, 12 Jul 2026 19:53:17 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-2387604828974757268</guid><description>Dissolution testing is recognized as one of the primary quality control tests for solid dosage forms. It shows how quickly and how much of the active ingredient (API) can be released from the tablets or capsules in the specified dissolving media. As a result, since the dissolution characteristics have a direct impact on drug release and thus bioavailability, the importance of this test is </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgBvRZyOfmEkUYGRlYi1gZWJoFwanJCTch7rMdIZrcFZF8DzJpi7Ng8vBQA8QrX14n1EFHvpiZQx4sIUiCRn1QyDpeK18SUcqhPJgIehvTyR2HSlSg2MIKzb83AMCsZAI0Kt-9n86rRjYbMQswAhJnhe_ogGPSL0sqAshPex0SV_lytEAf7AYhH0qPK9G06/s72-c/dissolution-validation.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Validation Policy in Pharmaceuticals | Purpose, Scope and Benefits</title><link>https://www.pharmaguideline.com/2026/07/validation-policy-in-pharmaceutical.html</link><category>GDP</category><category>Regulatory</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Fri, 10 Jul 2026 20:58:04 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-825790381983240695</guid><description>Validation is one of the main aspects of pharmaceutical quality assurance. It establishes documented proof that facilities, utilities, equipment, processes, cleaning procedures, analytical methods and computerized systems operate in the required way. Validation policies prescribe how the validation process will be managed in the facility while validation reports are applicable to particular </description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjrWoW48T0uOSwDfQY-5hhpeaPOuGAGRR6Txl5bIEFDlYR0anpyDv-3f0gRUtdWlGpT4-NcsevqpWKsQldgvzhxv66dXWn0jyz6MElCEO-Ov22vC2ADFqjvCPrapg6vq8Sr-7npwYA2NRKmiwAAEhaaUS-tSC5zM8dV50SY2rWKaSZaBTC9EruYnuWoA-di/s72-c/quality-policy.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item><item><title>Validation of Electronic Logbooks in Pharmaceutical Manufacturing</title><link>https://www.pharmaguideline.com/2026/07/validation-of-electronic-logbooks.html</link><category>Data Integrity</category><category>GDP</category><category>Validation</category><author>noreply@blogger.com (Dr. Ankur Choudhary)</author><pubDate>Wed, 8 Jul 2026 22:43:19 +0530</pubDate><guid isPermaLink="false">tag:blogger.com,1999:blog-2032508520370173515.post-8047976252909199668</guid><description>Because of the need to enhance efficiency and to minimize data errors and strengthen data integrity, the pharmaceutical sector is currently making the transition from paper-based records to e-systems.  This trend is exemplified by the fact that more and more equipment operation logs, cleaning practices records, calibration logs, maintenance records, environmental and utility operation records are</description><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" height="72" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhHgMelizWBagRHyQ-fdlDZ5vzhPDVGh1c4G_9fn7EKOokQW6Ween3RxrLulDBXsLufMCb4v6BnjFJU8PyZzH9wH4PDwqtlN1jgR-HKnG640UDXaoYFB5nCfryqOZQnTceT6kthzTBWNI5BkwGxHX5HAbsZhmCLBpmsenG-pgVXVw-iKnMBJHnwMk5e0LQu/s72-c/e-logbooks.jpeg" width="72"/><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total></item></channel></rss>